|
Addgene inc
lentiviral pwpi backbone ![]() Lentiviral Pwpi Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/pWPI+(Plasmid+%2312254)/pmc12851572-174-18-21 Average 95 stars, based on 1 article reviews
lentiviral pwpi backbone - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
Addgene inc
pwpt lentiviral vector backbone ![]() Pwpt Lentiviral Vector Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/pWPT-GFP+(Plasmid+%2312255)/pmc04829662-145-33-39 Average 94 stars, based on 1 article reviews
pwpt lentiviral vector backbone - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Addgene inc
plvthm ![]() Plvthm, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/pLVTHM-shSCR+(Plasmid+%2338034)/10__1161_slash_jaha__118__010240-392-85-75 Average 91 stars, based on 1 article reviews
plvthm - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
Addgene inc
shrna against mpinx1 ![]() Shrna Against Mpinx1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/shRNA+(Plasmid+%2355783)/pmc07335523__JAH3___9___e010240___s001-47-35-52 Average 96 stars, based on 1 article reviews
shrna against mpinx1 - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
SIRION Biotech
adjuvant lentiboost ![]() Adjuvant Lentiboost, supplied by SIRION Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/lentiboost/pm36917008-327-8-10 Average 90 stars, based on 1 article reviews
adjuvant lentiboost - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Addgene inc
human ace2 ![]() Human Ace2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/pWPI-IRES-Puro-Ak-ACE2+(Plasmid+%23154985)/pmc08787138-58-19-21 Average 93 stars, based on 1 article reviews
human ace2 - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Addgene inc
plasmid pmd2 g ![]() Plasmid Pmd2 G, supplied by Addgene inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/pMD2%2EG+(Plasmid+%2312259)/pmc10240187-194-11-26 Average 98 stars, based on 1 article reviews
plasmid pmd2 g - by Bioz Stars,
2026-09
98/100 stars
|
Buy from Supplier |
|
Addgene inc
eral1 egfp ![]() Eral1 Egfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/ERAL1+(Plasmid+%23155585)/pmc07610405-9-20-12 Average 93 stars, based on 1 article reviews
eral1 egfp - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Addgene inc
ddx28 egfp ![]() Ddx28 Egfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/DDX28+(Plasmid+%23155515)/pmc07610405-9-19-12 Average 92 stars, based on 1 article reviews
ddx28 egfp - by Bioz Stars,
2026-09
92/100 stars
|
Buy from Supplier |
|
Addgene inc
n a lentivirus pci h2b rfp vector backbone ![]() N A Lentivirus Pci H2b Rfp Vector Backbone, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/pCI+H2B-RFP+(Plasmid+%2392398)/pm36152303-168-9-21 Average 93 stars, based on 1 article reviews
n a lentivirus pci h2b rfp vector backbone - by Bioz Stars,
2026-09
93/100 stars
|
Buy from Supplier |
|
Addgene inc
fastkd2 trfp ![]() Fastkd2 Trfp, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/FASTKD2+(Plasmid+%23155600)/bio_rxiv__747055-10-18-12 Average 92 stars, based on 1 article reviews
fastkd2 trfp - by Bioz Stars,
2026-09
92/100 stars
|
Buy from Supplier |
|
GSL Biotech
snapgene software ![]() Snapgene Software, supplied by GSL Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pwpi+lentiviral+backbone/snapgene+software/bio_rxiv__124297-246-22-24 Average 90 stars, based on 1 article reviews
snapgene software - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Human Immunity
Article Title: A heterozygous USB1 variant linked to immunodeficiency
doi: 10.70962/jhi.20250110
Figure Lengend Snippet: The USB1 de novo variant is catalytically active and correctly processes U6 snRNA. (A) Total RNA extracted from the indicated BEBV cell lines were treated with T4 PNK or with buffer only (PNKBuff) in mild acidic conditions. RNA was subsequently treated with poly(A) polymerase (PAP). Nontreated RNA was loaded as a control, ( n = 2). (B) 3′ RACE analysis of U6 oligo(U) tails in the indicated cell lines. At least 24 clones per sample in each experiment ( n = 2) were sequenced. Bars and error bars are averages of the number of U's within U6 oligo(U) tails and SEM from two independent experiments. (C and D) Indicated cell lines were treated with actinomycin D for 0, 4, and 8 h. RNA samples were processed by northern blotting for detection of U6 and 5S ( n = 2). L: marker of known length (67 nucleotides). U6 signals were normalized through the corresponding 5S signals and successively expressed as fold decrease over U6 signal at time 0. Error bars are averages of SEM from two independent experiments. (E and F) U6 relative abundance quantification by qPCR analysis on patients and control cell lines (ctr1 n = 2, ctr2 n = 3, ctr3 n = 1, USB1 −/− n = 3, P1 n = 3) (E), and USB1 −/− cells transduced with the indicated lentiviral constructs ( n = 2) (F). U6 signals were normalized through the corresponding 5S signals and successively expressed as fold decrease over U6 signal at time 0. Error bars are averages of SEM from two independent experiments. EV, empty vector. Source data are available for this figure: .
Article Snippet: Those inserts (with the addition of an HA tag at the C-terminal when indicated) were subcloned into the
Techniques: Variant Assay, Control, Clone Assay, Northern Blot, Marker, Transduction, Construct, Plasmid Preparation
Journal: Nature Communications
Article Title: Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming
doi: 10.1038/ncomms11208
Figure Lengend Snippet: ( a ) TF expression in hPSCs versus cbMKs plotted as a row normalized heatmap with indications of recorded TF internal and chromatin modifiers node numbers and protein interactions among the top 20 TF candidates reported by VisANT. The nine experimentally tested TFs are highlighted in red. ( b ) The H9 hESC line was concurrently transduced with the 9-TFs and maintained in pluripotency medium (FGF2+Activin-A) for 2 days followed by MK medium (TPO+SCF) for a further 5 days. CD41a+ cells generated 7 days after lentiviral transduction (dot plot, mean% ±s.e.m., n =5; FL1: 530/40 nm channel) were sorted by flow cytometry and transgene expression levels quantified by RT-qPCR ( n =1). ( c ) The percentage of CD41a+ cells was monitored by flow cytometry 7 days after transduction of the hiPSC lines #1 and #2 with the 9-TFs or 3-TFs combination. Bar graphs represent the fold increase of CD41a+ cell count relative to the 9-TFs combination (mean ±s.e.m., n =4; ** P< 0.01 by two-tail t -test). NT: non-transduced cells. ( d ) The hiPSC#1 line was transduced with all permutations of the 3-TFs and percentages of CD41a+ cells measured by flow cytometry at day 7. Bar graphs represent the fold increase of CD41a+ cell count relative to the 3-TFs combination (mean ±s.d., n =2; * P =0.06 and P< 0.01 versus G+F and other combination respectively by two-tail t -test). G: GATA1, F: FLI1, T: TAL1, GFP: control vector. ( e ) The endogenous expression of key MK genes was monitored by RT-qPCR from CD41a flow sorted cells 7 days after transduction of the hiPSC lines #1 and #2 (mean ±s.d., n =2). ( f ) The hiPSC lines #1 and #2 were transduced with the 3-TFs and sorted by flow cytometry for expression of CD41a at day 7. The clonogenic potential of sorted cells was tested in methylcellulose semi-solid medium supplemented with TPO and SCF. The number of colonies per 5,000 sown cells was determined after 10 days from duplicate wells (mean±s.e.m., n =4). ( g ) A representative MK colony obtained from a CD41a+ cell co-expressing CD41a and CD42b as detected by immunofluorescence is shown (scale bar, 50 μm).
Article Snippet: The human coding sequences of the nine candidate genes (variants 1 from NCBI Reference Sequence Database) including the 5′ Kozak consensus sequence were generated by PCR using cbMK cDNA, individually cloned into the
Techniques: Expressing, Transduction, Generated, Flow Cytometry, Quantitative RT-PCR, Cell Counting, Control, Plasmid Preparation, Immunofluorescence
Journal: Frontiers in Immunology
Article Title: Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection
doi: 10.3389/fimmu.2021.813240
Figure Lengend Snippet: Two opposing roles of RBD-reactive antibodies in SAR-CoV-2 infection. (A) Bar graph of the neutralizing activity of individual samples. Gray dotted lines denote 25% neutralization (upper) and -25% neutralization (lower). (B) Box plot representing the RBD-reactive antibody levels in three groups according to the nature of ACE2-mediated SARS-CoV-2 viral infection. EN, enhancing group; NT, neutralizing group; NA, not affecting group. * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001 (unpaired Student’s t-test); NS, not significant (unpaired Student’s t-test).
Article Snippet: Lentiviral VSV G pseudotypes packaging human ACE2 were produced under the same platform with a lentiviral backbone plasmid encoding
Techniques: Infection, Activity Assay, Neutralization